Unique Pathology Lab Private Limited - Due diligence report

A 360° intelligence report on Unique Pathology Lab Private Limited: trust score, financial health, credit view, compliance, directors, growt…

2010-03-15 Delhi, Delhi Active Unlisted Active Compliant
Share
View plans
UP Unique Pathology Lab Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹349 50% off New user
Or enjoy up to 50% off with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Unique Pathology Lab Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
75/100
Trust Score
Low Risk

Unique Pathology Lab Private Limited is assessed as Low Risk with a Trust Score of 75/100. Unique Pathology Lab Private Limited is an active private limited indian non-government company incorporated in 2010, operating in the Healthcare sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.

Report generated on 29 Jun 2026 from the latest processed filings. Unique Pathology Lab Private Limited snapshot & full profile →

Financial Health › Neutral
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Strong

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
75/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreLow Risk
81/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreModerate
50/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreModerate
65/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreLow Risk
95/100
Revenue, profit, asset and hiring momentum.
Distress ScoreModerate
70/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Standalone · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 65/100 Moderate
  • Profitable - internal accruals available.

Charges position: 2 open (35.00 Lakh) · 0 satisfied (-).

Banking relationships (from registered charges)
LenderChargesAmount
Bank Of Baroda1 48.0 cr
Ge Capital Services India1 48.0 cr
Compliance Score: 81/100 Low Risk
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
  • Litigation present in 1 court forum(s).
Legal cases on record (1)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
VIRENDER BHARDWAJ 01234567 Director 01/04/2018 6 yrs Approved
PARVEEN BANSAL 01234567 Director 01/04/2018 6 yrs Approved
NEERAJ KUMAR GROVER 01234567 Director 01/04/2018 6 yrs Approved
BINDU DEVI 01234567 Director 01/04/2018 6 yrs Approved
SITA RAM BANSAL 01234567 Director 01/04/2018 6 yrs Approved
  • 5 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2022)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2022 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
-
Group entities
-
Capital events
1 allotment(s) · 2 transfer(s)

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 95 · Distress 70
Growth signals & trust indicators
Revenue acceleration: +38% over 4 year(s).
Latest year revenue grew 1.42.
Profit expanded 2.1x year-on-year.
Asset base grew 24% - capacity expansion.
Net margin improved to 0.86.
Operating for 16+ years.
Distress signals & risk flags
Negative net worth.
2 open charge(s) registered - assets are encumbered.
1 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence76/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Statutory record is clean.
  • 1 distress signal(s) - see Risk Center.
  • Financial filings available for verification.
Banker assessment64/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 2 open charge(s) of 35.00 Lakh already registered.
  • Compliance record supports lending.
Investor view74/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 5 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
02 Dec 2025
Director appointed
PARVEEN BANSAL (Director)
Director appointed
SITA RAM BANSAL (Director)
30 Sep 2024
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
18 Mar 2021
Director ceased
NIRANJAN AGARWAL LAL
15 Jan 2021
Director appointed
VIRENDER BHARDWAJ (Director)
Director appointed
BINDU DEVI (Director)
15 Oct 2020
Director ceased
CHARU GROVER
31 Mar 2019
Share transfer (FY 2019)
15000.00000000 shares to Neeraj Grover
Share transfer (FY 2019)
10000.00000000 shares to Neeraj Grover
31 Mar 2012
Securities allotted
76000.00 Equity Shares - 7.60 Lakh raised
07 Dec 2010
Charge created
Bank Of Baroda - 24.50 Lakh
22 Sep 2010
Charge created
Ge Capital Services India - 10.50 Lakh
25 Jun 2010
Director ceased
YOGESH GROVER
Director ceased
UTTAM PRAKASH TIWARI
10

Key Observations

Auto-generated from the data above
Revenue grew 61% over the last 4 financial year(s).
Net profit margin moved from 38% to 1.42.
Compliance record is strong - status, filings and flags are clean.
5 active director(s) / partner(s); board looks stable and experienced.
Promoters hold a dominant controlling stake as per the FY 2022 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
Capital has been raised through 1 security allotment(s) - amounts available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Impact Diagnostic Private Limited U85195AS2007PTC008469 Guwahati, Assam, India
Savera Diagnostics Private Limited U85100PB2010PTC034443 Moga, Punjab, India
Spectrum Radiodiagnostics (Mumbai) Private Limited U85195MH2011PTC217015 Dombivli, Maharashtra, India
Sapiens Biotec Private Limited U85310PN2016PTC167187 Punr, Maharashtra, India
Liferoute Healthcare Private Limited U85100TN2013PTC094071 Chennai, Tamil Nadu, India
Urvaraa Ivf Medical Research Centre Private Limited U85190WB2018PTC227200 Kolkata, West Bengal, India
Niranjan Aarogya Niketan & Research Centre Private Limited U85100BR2016PTC025639 Bhikhna Pahari, Bihar, India
Benito Therapeutic Private Limited U24100MH2019PTC333210 Mumbai, Maharashtra, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Unique Pathology Lab Private Limited before audits and certifications: compliance score 81/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Unique Pathology Lab Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 65/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 95/100, margin trends, ownership structure and peer set for Unique Pathology Lab Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 75/100, distress signals and MSME payment-delay disclosures - know whether Unique Pathology Lab Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (1 case(s) on record), regulatory flags, charge documents trail and director networks for Unique Pathology Lab Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Unique Pathology Lab Private Limited an active company?

Unique Pathology Lab Private Limited has MCA status “Active” with a compliance score of 81/100 (Low Risk).

Is Unique Pathology Lab Private Limited financially healthy?

Unique Pathology Lab Private Limited has a Financial Health Score of 50/100 (Moderate) based on its filed financial statements.

Should I do business with Unique Pathology Lab Private Limited?

Its overall Trust Score is 75/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Unique Pathology Lab Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 5 active director(s) are on record.

Does Unique Pathology Lab Private Limited have loans or charges against its assets?

2 open charge(s) are registered against its assets.

Is Unique Pathology Lab Private Limited up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 81/100 (Low Risk).

Is it risky to lend to Unique Pathology Lab Private Limited?

Its Credit Risk Score is 65/100 (Moderate). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.